The most commonly reported adverse events across all treatment arms were gastrointestinal-related, including nausea (17.4 percent [5 mg], 19.2 percent [10 mg], 22.1 percent [15 mg], 17.9 percent [semaglutide]), diarrhea (13.2 percent [5 mg], 16.4 percent [10 mg], 13.8 percent [15 mg], 11.5 percent [semaglutide]) and vomiting (5.7 percent [5 mg], 8.5 percent [10 mg], 9.8 percent [15 mg], 8.3 percent [semaglutide])
Retatrutide does act on the GLP-1 receptor, but it is not a GLP-1-only medication like semaglutide
Ponytails getting noticeably thinner over weeks
Some people also experience headaches, dizziness, or mild injection site reactions
Why people use it: Proponents claim it may speed up postworkout recovery, reduce acute inflammation, improve athletic performance, help you heal faster from an injury or surgery, treat inflammatory bowel issues or other gastrointestinal (GI) symptoms, or even cure a hangover